Vergleich

Anti-Mouse PD-L2 (B7-DC) - Purified <i>in vivo </i>GOLD™ Functional Grade - 25 mg

ArtNr LEIN-C2292-25mg
Hersteller Leinco Technologies
Menge 25 mg
Quantity options 1 mg 100 mg 25 mg 5 mg 50 mg
Kategorie
Typ Antibody Monoclonal
Applikationen WB, FC, IP, IHC, IV
Clon TY25
Specific against Mouse (Murine, Mus musculus)
Host Rat
Purity ≥95% monomer by analytical SEC, > 95% by SDS Page
NCBI 58205
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Versandbedingung Gekühlt
Lieferbar
Manufacturer - Applications
FC, IHC FF, in vivo, IP, WB
Manufacturer - Category
Purified in vivo Functional Grade>Gold Purified Bulk Antibodies|Primary Monoclonal Antibodies>Immune Checkpoints|Primary Monoclonal Antibodies>Surfacetag Mouse CD Markers
Manufacturer - Targets
PD-L2
Country of Origin
USA
Shipping Temperature
Next Day 2 - 8°C
Storage Conditions
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles.
Product Description
PD-L2 antibody, clone TY25, recognizes mouse programmed death ligand 2 (PDL-2), also known as B7-DC and CD273. PD-L2 is a 42 kDa type I transmembrane glycoprotein that belongs to the B7 family of the immunoglobulin (Ig) receptor superfamily. PD-L2 is an inhibitory ligand primarily expressed on antigen-presenting cells, including macrophages and a subset of dendritic cells (DCs). Its receptor, PD-1, is expressed by CD4-CD8- thymocytes as well as CD4 and CD8 T cells, monocytes, DCs, and B cells upon activation1. Binding of PD-L2 to PD-1 on CD4 and CD8 T cells inhibits T cell receptor (TCR) signaling, negatively regulating T cell proliferation, cytokine production, and cytotoxic activity2. PD-L2 is expressed on many tumor types3, 4 and is associated with unfavorable prognosis in patients with solid tumors5.
Background
PD-L2 antibody, clone TY25, recognizes mouse programmed death ligand 2 (PDL-2), also known as B7-DC and CD273. PD-L2 is a 42 kDa type I transmembrane glycoprotein that belongs to the B7 family of the immunoglobulin (Ig) receptor superfamily. PD-L2 is an inhibitory ligand primarily expressed on antigen-presenting cells, including macrophages and a subset of dendritic cells (DCs). Its receptor, PD-1, is expressed by CD4-CD8- thymocytes as well as CD4 and CD8 T cells, monocytes, DCs, and B cells upon activation1. Binding of PD-L2 to PD-1 on CD4 and CD8 T cells inhibits T cell receptor (TCR) signaling, negatively regulating T cell proliferation, cytokine production, and cytotoxic activity2. PD-L2 is expressed on many tumor types3, 4 and is associated with unfavorable prognosis in patients with solid tumors5.
Other Applications Reported In Literature
IHC FF
IP
PubMed
PD-L2
Ligand/Receptor
PD-1, uncharacterized receptor
Manufacturer - Research Area
Costimulatory Molecules, Immunology
Manufacturer - Specificity
Clone TY25 recognizes an epitope on mouse PD-L2. TY25 does not cross-react with PD-L1.
RRID
AB_2749822
Concentration
≥ 5.0 mg/ml
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Product Preparation
Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Antigen Distribution
PD-L2 is expressed on macrophages and a subset of dendritic cells (DCs).
Immunogen
Purified transfected mouse B7-DC cell line
Additional Information
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Keywords
PD-L2, B7-DC, CD273, PDL2, B7DC, 3.2, mouse B7-DC, PD-L2, PDL2, B7DC, B7-DC, bA574F11.2, Btdc, Butyrophilin B7-DC, Butyrophilin-like Protein, CD273 antigen, CD273, MGC142240, PDCD1L2MGC142238, PDCD1LG2, PDL2, PD-L2, PDL2B7DC, PD-L2PDCD1 ligand 2, programmed cell death 1 ligand 2, Programmed death ligand 2, B7 dendritic cell molecule, mouse B7-DC, mouse B7DC, bA574F11.2, Btdc, Butyrophilin B7-DC, butyrophilin-like protein, CD273, PDL2, PDCD1 ligand 2, PDCD1L2, mouse PDL2, Programmed cell death 1 ligand 2, programmed death ligand 2, B7-DC, B7DC, bA574F11.2, Btdc, CD273, F730015O22Rik, mouse PD-L2, PDCD1L2, PDCD1LG2, PDL2

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 25 mg
Lieferbar: In stock
lieferbar

Lieferung vsl. bis 02.10.2025 

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen